Study shows the power of the “argument dilution effect”
Plasma from young people offers “no proven clinical benefit” as a treatment against aging or Alzheimer’s disease, the agency says
A tortoise and a puffer fish inspire technology to overcome the multibillion-dollar nonadherence problem
At NewYork-Presbyterian Hospital and its affiliated medical schools, Columbia University College of Physicians and Surgeons and Weill Cornell Medical College, innovators in science and medicine are pursuing cancer research with the potential to redefine the field...
Turns out, bringing together patients, caregivers, advocates and researchers could lead to better outcomes. Here’s how to begin.
Killing ticks and inoculating people has failed, so researchers try immunizing mice via vaccine-laced food
Promoters hope efforts will also offer insights into treatments used for humans
The World Health Organization predicts the Democratic Republic of the Congo has enough of the experimental vaccine
Dietary supplements aren’t drugs, but the ingredients they contain are often highly bioactive. Ensuring consumer safety for these ‘natural’ products is a big job.
Scientists are working to correct a genetic defect in cystic fibrosis patients by having them inhale RNA. Christopher Intagliata reports.
Drugs could be more effective if taken when the genetic proteins they target are most active
A potent molecular cocktail containing a compound from ayahuasca spurs rapid growth of insulin-producing cells
For decades, antisense technology promised to transform the pharmaceutical industry. That moment has now arrived. Dr. Stanley Crooke, a pioneer in the field, explains what’s next.
The global biopharmaceutical industry has undergone rapid change within the past decade, reflecting and shaping the way new drugs are discovered, produced and sold. Singapore is consolidating its global position as a pharmaceutical manufacturing hub through a supportive pharma ecosystem and a focus on people and partnerships...
Experts say the risks of a controversial procedure outweigh the benefits for twin newborns
Sometimes infecting volunteers with a disease can lead to new treatments. But how much risk and compensation is acceptable for those in poor nations?
The Democrats campaigned on protecting coverage for people with pre-existing conditions and lowering prescription drug prices
The "low hanging fruit" of genome-related health care will be knowing which drugs are likely to treat you best, says science journalist Carl Zimmer.
The decision was made despite criticism that the drug could be a danger to public health
Xofluza is the first drug with a new mechanism of action to be approved in nearly 20 years